128 related articles for article (PubMed ID: 16455947)
1. STAT5-induced self-renewal and impaired myelopoiesis of human hematopoietic stem/progenitor cells involves down-modulation of C/EBPalpha.
Wierenga AT; Schepers H; Moore MA; Vellenga E; Schuringa JJ
Blood; 2006 Jun; 107(11):4326-33. PubMed ID: 16455947
[TBL] [Abstract][Full Text] [Related]
2. Maximal STAT5-induced proliferation and self-renewal at intermediate STAT5 activity levels.
Wierenga AT; Vellenga E; Schuringa JJ
Mol Cell Biol; 2008 Nov; 28(21):6668-80. PubMed ID: 18779318
[TBL] [Abstract][Full Text] [Related]
3. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
[TBL] [Abstract][Full Text] [Related]
4. Reintroduction of C/EBPalpha in leukemic CD34+ stem/progenitor cells impairs self-renewal and partially restores myelopoiesis.
Schepers H; Wierenga AT; van Gosliga D; Eggen BJ; Vellenga E; Schuringa JJ
Blood; 2007 Aug; 110(4):1317-25. PubMed ID: 17475913
[TBL] [Abstract][Full Text] [Related]
5. Signal transducer and activator of transcription 5a (STAT5a) is required for eosinophil differentiation of human cord blood-derived CD34+ cells.
Buitenhuis M; Baltus B; Lammers JW; Coffer PJ; Koenderman L
Blood; 2003 Jan; 101(1):134-42. PubMed ID: 12393707
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of GATA1 uncouples STAT5-induced erythroid differentiation from stem/progenitor cell proliferation.
Wierenga AT; Vellenga E; Schuringa JJ
Blood; 2010 Jun; 115(22):4367-76. PubMed ID: 20339093
[TBL] [Abstract][Full Text] [Related]
7. STAT5 is required for long-term maintenance of normal and leukemic human stem/progenitor cells.
Schepers H; van Gosliga D; Wierenga AT; Eggen BJ; Schuringa JJ; Vellenga E
Blood; 2007 Oct; 110(8):2880-8. PubMed ID: 17630355
[TBL] [Abstract][Full Text] [Related]
8. Enforced activation of STAT5A facilitates the generation of embryonic stem-derived hematopoietic stem cells that contribute to hematopoiesis in vivo.
Schuringa JJ; Wu K; Morrone G; Moore MA
Stem Cells; 2004; 22(7):1191-204. PubMed ID: 15579639
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of STAT5A promotes human hematopoietic stem cell self-renewal and erythroid differentiation.
Schuringa JJ; Chung KY; Morrone G; Moore MA
J Exp Med; 2004 Sep; 200(5):623-35. PubMed ID: 15353555
[TBL] [Abstract][Full Text] [Related]
10. Identification of HIF2alpha as an important STAT5 target gene in human hematopoietic stem cells.
Fatrai S; Wierenga AT; Daenen SM; Vellenga E; Schuringa JJ
Blood; 2011 Mar; 117(12):3320-30. PubMed ID: 21263150
[TBL] [Abstract][Full Text] [Related]
11. Ectopic expression of C/EBPalpha and ID1 is sufficient to restore defective neutrophil development in low-risk myelodysplasia.
Geest CR; Buitenhuis M; Vellenga E; Coffer PJ
Haematologica; 2009 Aug; 94(8):1075-84. PubMed ID: 19644139
[TBL] [Abstract][Full Text] [Related]
12. STAT5 requires the N-domain to maintain hematopoietic stem cell repopulating function and appropriate lymphoid-myeloid lineage output.
Li G; Wang Z; Zhang Y; Kang Z; Haviernikova E; Cui Y; Hennighausen L; Moriggl R; Wang D; Tse W; Bunting KD
Exp Hematol; 2007 Nov; 35(11):1684-94. PubMed ID: 17976521
[TBL] [Abstract][Full Text] [Related]
13. Differential contributions of STAT5A and STAT5B to stress protection and tyrosine kinase inhibitor resistance of chronic myeloid leukemia stem/progenitor cells.
Casetti L; Martin-Lannerée S; Najjar I; Plo I; Augé S; Roy L; Chomel JC; Lauret E; Turhan AG; Dusanter-Fourt I
Cancer Res; 2013 Apr; 73(7):2052-8. PubMed ID: 23400594
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of signal transducer and activator of transcription 5 (STAT5) in CD34+ cells promotes megakaryocytic development, whereas activation of STAT5 drives erythropoiesis.
Olthof SG; Fatrai S; Drayer AL; Tyl MR; Vellenga E; Schuringa JJ
Stem Cells; 2008 Jul; 26(7):1732-42. PubMed ID: 18436865
[TBL] [Abstract][Full Text] [Related]
15. Induction of C/EBPalpha activity alters gene expression and differentiation of human CD34+ cells.
Cammenga J; Mulloy JC; Berguido FJ; MacGrogan D; Viale A; Nimer SD
Blood; 2003 Mar; 101(6):2206-14. PubMed ID: 12406909
[TBL] [Abstract][Full Text] [Related]
16. STAT5A regulates DNMT3A in CD34(+)/CD38(-) AML cells.
Takeuchi A; Nishioka C; Ikezoe T; Yang J; Yokoyama A
Leuk Res; 2015 Aug; 39(8):897-905. PubMed ID: 26059451
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase B (c-akt) regulates hematopoietic lineage choice decisions during myelopoiesis.
Buitenhuis M; Verhagen LP; van Deutekom HW; Castor A; Verploegen S; Koenderman L; Jacobsen SE; Coffer PJ
Blood; 2008 Jan; 111(1):112-21. PubMed ID: 17890457
[TBL] [Abstract][Full Text] [Related]
18. The gene encoding the hematopoietic stem cell regulator CCN3/NOV is under direct cytokine control through the transcription factors STAT5A/B.
Kimura 木村丹香子 A; Martin C; Robinson GW; Simone JM; Chen W; Wickre MC; O'Shea JJ; Hennighausen L
J Biol Chem; 2010 Oct; 285(43):32704-32709. PubMed ID: 20720003
[TBL] [Abstract][Full Text] [Related]
19. Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation.
Piacibello W; Sanavio F; Garetto L; Severino A; Dané A; Gammaitoni L; Aglietta M
Leukemia; 1998 May; 12(5):718-27. PubMed ID: 9593270
[TBL] [Abstract][Full Text] [Related]
20. In Vivo Deletion of the Cebpa +37 kb Enhancer Markedly Reduces Cebpa mRNA in Myeloid Progenitors but Not in Non-Hematopoietic Tissues to Impair Granulopoiesis.
Guo H; Cooper S; Friedman AD
PLoS One; 2016; 11(3):e0150809. PubMed ID: 26937964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
